
The majority of Directors of Investor Relations at Bartell Drugs believe they're not compensated fairly. 50% of Directors of Investor Relations at Bartell Drugs say they receive annual bonuses, and the majority (50%) are satisfied with their benefits. See more compensation ratings at Bartell Drugs